
    
      The patients will be enrolled before surgery and follow-up during 18 months. During patient
      participation, 20 ml of blood will be collected 7 times (before and after surgery, 6 months
      after diagnosis and every 3 months thereafter until 18 months of follow up).

      Mutation analysis on tumor and healthy tissue will be performed on primary tumors and lymph
      node dissection, after removal by the surgeon.

      Circulating tumor DNA will be detected on blood sample
    
  